Anlotinib Not Yet Recruiting Phase 2 Trials for Soft Tissue Sarcoma (STS) / Undifferentiated Pleomorphic Sarcoma Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03946943Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma